Search
This site uses cookies
By clicking “Accept,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
As of 2026, DSCSA compliance continues to be an important priority for pharmacies. The Drug Supply Chain Security Act is designed to create an electronic, interoperable system for tracing certain prescription drugs at the package level as they move through the supply chain.
While the FDA granted exemptions beyond the stabilization period for manufacturers, repackagers, wholesale distributors, and dispensers with 26 or more full-time employees, those dates have now passed or are approaching depending on the trading partner type. Small dispensers received additional time until November 27, 2026, for certain enhanced DSCSA requirements. For this exemption, the FDA defines a small dispenser as a company that owns the dispenser and has 25 or fewer full-time employees licensed as pharmacists or qualified as pharmacy technicians as of November 27, 2024.
This extension does not mean pharmacies should pause their compliance efforts. Small dispensers should continue working toward implementation, reviewing their systems, training staff, and preparing the workflows needed to meet enhanced drug distribution security requirements.
Learn what you need to know about DSCSA compliance for pharmacies.
The Drug Quality and Security Act (DQSA) was passed on November 27, 2013. Title 2 of the DQSA, the Drug Supply Chain Security Act (DSCSA) presents steps to “achieve interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States.”
The DSCSA helps protect patients from exposure to counterfeit, contaminated, stolen, or harmful medications.
Most DSCSA compliance requirements are already in place. The November 27, 2023 (which is also the 10th anniversary of the DQSA’s passing) deadline was the second phase of DSCSA, which launched the Track and Trace serialization law.
InfiniTrak President Mark Tate goes over the basics of DSCSA compliance on the Catalyst Pharmacy Podcast. Tune in here:
Most of the aspects of DSCSA are already in place. Learn more about these requirements to see if your pharmacy is compliant.
As of July 2026, here are the current DSCSA guidelines your independent pharmacy needs to be following.
The main focus of DSCSA compliance is between your pharmacy and your drug suppliers. Licensure verification is required for all drug suppliers, no matter how often or rarely you use them.
Likewise, do not rely on drug suppliers or manufacturers to cover your DSCSA-related bases. This is all about making sure your pharmacy stays DSCSA compliant. When it comes to compliance between your pharmacy and drug suppliers, you can’t have one without the other.
A common practice in independent pharmacies, selling or lending products to another pharmacy now has to be done within DSCSA guidelines.
If your pharmacy is the one selling or lending products to another pharmacy, you must provide complete and accurate transaction data with the drug. It might seem tedious at first but will make DSCSA compliance easier in the long run.
Continuing with your relationship with drug suppliers, make sure their electronic data is complete, accurate, and stored for six years.
DSCSA compliance is ensuring your pharmacy can detect any counterfeit or harmful medications before they reach your patient.
Your pharmacy must have Standard Operating Procedures (SOPs) to identify suspect or illegitimate products. Make sure you document the process, which should always consist of notifying the FDA and drug supplier of the counterfeit product.
This is a brief rundown of what your pharmacy should already be doing within DSCSA compliance. Now let’s see what you need to do by the November 27, 2026 DSCSA deadline.
While several DSCSA implementation deadlines have already passed for manufacturers, repackagers, wholesale distributors, and larger dispensers, small dispensers have been granted additional time to meet certain enhanced DSCSA requirements. For qualifying small dispensers, the current DSCSA deadline is November 27, 2026.
That extra time should be used wisely. If your pharmacy qualifies as a small dispenser, now is the time to review your current processes, confirm that your systems can support DSCSA requirements, train your staff, and work with your vendors and trading partners to prepare for full implementation. Between now and the November 27, 2026, deadline, make sure your pharmacy is moving toward DSCSA compliance in the following ways:
Chances are your pharmacy receives data through an EDI (electronic data interchange) format. DSCSA compliance requires you to move over to the EPCIS (Electronic Product Code Information Services) format.
As a result of this requirement, EDI data will no longer be a part of DSCSA compliance.
Per the FDA, “EPCIS is an appropriate globally recognized standard, and [...] there is considerable agreement among stakeholders that EPCIS is a suitable standard to adopt for the enhanced drug distribution security requirements.
DSCSA compliance requires you to manually enter and scan products at intake
Most pharmacists already receive their shipments this way, but things might look different for fill facilities or larger pharmacies.
DSCSA compliance requires you to manually enter and scan products at intake. You also must confirm all products have a product identifier, such as a 2D Barcode.
PioneerRx’s 2D Barcode scanning feature makes this part of DSCSA compliance simple.
RedSail Technologies’ Director of Education and Training Erin Dalton talks about the importance of this aspect of DSCSA compliance:
“2D barcode scanning allows pharmacies to capture product information and identify any inconsistencies from any electronic files sent by trading partners. This lets pharmacists quickly remove said products from the supply chain for suspected counterfeiting.”
Once DSCSA is in effect, a dispenser can request the status of a certain drug, requiring the manufacturer to respond electronically on the status of the product in question within 24 hours.
As with nearly all aspects of DSCSA compliance, have a plan in place to handle product verification requests. It could affect your pharmacy’s workflow when you or a manufacturer have to present the product information within a tight time window.
DSCSA compliance requires reliable workflows for scanning, documentation, product tracing, supplier coordination, and handling suspect or illegitimate products. PioneerRx helps support these efforts with tools that fit into the daily dispensing process, including 2D barcode scanning that can help capture important product details like lot information.
PioneerRx also connects pharmacies with DSCSA-focused vendor solutions designed to support dispenser compliance. Through connected vendors like InfiniTrak and LSPedia, pharmacies can access tools for track-and-trace requirements, EPCIS data management, trading partner verification, audit readiness, and other DSCSA-related workflows.
DSCSA compliance is shaping the future of pharmacy in the United States. Chains and independent pharmacies alike must adjust their workflow accordingly to ensure they are DSCSA compliant.
Just like pharmacy work, staying compliant is a continuous process. There’s always something new to learn.
Sam Pizzo and Mark Tate of InfiniTrak came on the Catalyst Pharmacy Podcast to discuss the ins and outs of DSCSA compliance. Tune in to learn more about what you need to know about DSCSA compliance.
Erin Dalton and Mark Tate held a webinar regarding DSCSA compliance and InfiniTrak’s role in helping your pharmacy stay compliant. Go to PioneerRx University to catch recordings of both the webinar and Q&A.
We want to hear from you! Take the survey!
